¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

À§¾Ï ȯÀÚ »îÀÇ Áú ¿¬±¸È¸ 2024 Ãá°è Çмú´ëȸ : 2024-04-20

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

À§¾Ï ȯÀÚ »îÀÇ Áú ¿¬±¸È¸ 2024 Ãá°è Çмú´ëȸ : 2024-04-20
±³À°ÀÏÀÚ : 2024-04-20
±³À°Àå¼Ò : Áß¾Ó´ëÇб³ ±¤¸íº´¿ø 5Ãþ ±èºÎ¼·È¦

±³À°ÁÖÁ¦ : À§¾Ï ȯÀÚ »îÀÇ Áú ¿¬±¸È¸ 2024 Ãá°è Çмú´ëȸ

ÁÖÃÖ±â°ü : ´ëÇÑÀ§¾ÏÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : À§¾Ï ȯÀÚ »îÀÇ Áú ¿¬±¸È¸

´ã´çÀÚ : ±èÁöÇý
¿¬¶ôó : 02-730-3760

À̸ÞÀÏ : kgca@kgca-i.or.kr

±³À°Á¾·ù : ¿Ü°ú

Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 4Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 0ºÐ

¼¼ºÎ¼ö°­·á : 0¿ø

ºñ°í


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±âŸ 04¿ù 20ÀÏ ±èºÎ¼·È¦ 13:00~13:05 °³È¸»ç Á¤»óÈ£(KOQUSS ȸÀå)

±âŸ 04¿ù 20ÀÏ ±èºÎ¼·È¦ 13:05~13:05 Ãà»ç ÀÌÁØÇà(´ëÇÑÀ§¾ÏÇÐȸ ȸÀå)

±âŸ 04¿ù 20ÀÏ ±èºÎ¼·È¦ 13:05~13:10 Ãà»ç ·ù±Ù¿ø(´ëÇÑÀ§¾ÏÇÐȸ ÀÌ»çÀå)

±âŸ 04¿ù 20ÀÏ ±èºÎ¼·È¦ 13:10~14:20 [ÁÂÀå] Recent Research for QOL in Gastric Cancer Patients Ȳ¼øÈÖ(ºÎ»êÀÇ´ë)

±âŸ 04¿ù 20ÀÏ ±èºÎ¼·È¦ 13:10~14:20 [ÁÂÀå] Recent Research for QOL in Gastric Cancer Patients ¼Û±ÝÁ¾(¼øõÇâÀÇ´ë)

±³À°½Ã°£ 04¿ù 20ÀÏ ±èºÎ¼·È¦ 13:10~13:30 QOL Outcomes Depending Anastomotic Methods (B1 vs. B2) ¹Ú½ÅÇý(±¹¸³¾Ï¼¾ÅÍ)

±³À°½Ã°£ 04¿ù 20ÀÏ ±èºÎ¼·È¦ 13:30~13:50 QOL Outcomes After Pylorus preserving Gastrectomy ¹ÚÀç±Õ(ºÎ»êÀÇ´ë)

±³À°½Ã°£ 04¿ù 20ÀÏ ±èºÎ¼·È¦ 13:50~14:10 QOL In Gastric Cancer Patients Treated with Immunotherapy ±¸µ¿È¸(¼º±Õ°üÀÇ´ë)

Åä·Ð 04¿ù 20ÀÏ ±èºÎ¼·È¦ 14:10~14:20 [Åä·ÐÀÚ] Discussion ±èµ¿¿í(´Ü±¹ÀÇ´ë)

Åä·Ð 04¿ù 20ÀÏ ±èºÎ¼·È¦ 14:10~14:20 [Åä·ÐÀÚ] Discussion À̼¼Áø(ÀüºÏÀÇ´ë)

±âŸ 04¿ù 20ÀÏ ±èºÎ¼·È¦ 14:20~15:30 [ÁÂÀå] Digital Interventions to Improve the QOL ·ù±Ù¿ø(±¹¸³¾Ï¼¾ÅÍ)

±âŸ 04¿ù 20ÀÏ ±èºÎ¼·È¦ 14:20~15:30 [ÁÂÀå] Digital Interventions to Improve the QOL ¾ÈÇý¼º(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 04¿ù 20ÀÏ ±èºÎ¼·È¦ 14:20~14:40 Digital Conversion of Cancer Patient Management °û¼ºµ¿(¿Ã¶ó¿îµå ´ÚÅͽº)

±³À°½Ã°£ 04¿ù 20ÀÏ ±èºÎ¼·È¦ 14:40~15:00 Digital Healthcare for Mental Health Promotion Á¶Ã¶Çö(°í·ÁÀÇ´ë)

±³À°½Ã°£ 04¿ù 20ÀÏ ±èºÎ¼·È¦ 15:00~15:20 Aftercare Digital Interventions for Gastric Cancer Patient ¹èÀ±Á¤(¸ÞµðÇ÷¯½º ¼Ö·ç¼Ç)

Åä·Ð 04¿ù 20ÀÏ ±èºÎ¼·È¦ 15:20~15:30 [Åä·ÐÀÚ] Discussion ±èÀº¿µ(°¡Å縯ÀÇ´ë)

Åä·Ð 04¿ù 20ÀÏ ±èºÎ¼·È¦ 15:20~15:30 [Åä·ÐÀÚ] Discussion ¼ÛÁ¤È£(¾ÆÁÖÀÇ´ë)

ÈÞ½Ä 04¿ù 20ÀÏ ±èºÎ¼·È¦ 15:30~15:50 Coffee Break .(.)

±âŸ 04¿ù 20ÀÏ ±èºÎ¼·È¦ 15:50~16:45 [ÁÂÀå] KOQUSS Research Session ±ÇÁ¤Çý(Ãæ³²ÀÇ´ë)

±âŸ 04¿ù 20ÀÏ ±èºÎ¼·È¦ 15:50~16:45 [ÁÂÀå] KOQUSS Research Session ¹ÎÀç¼®(µ¿³²±Ç¿øÀÚ·ÂÀÇÇпø)

±³À°½Ã°£ 04¿ù 20ÀÏ ±èºÎ¼·È¦ 15:50~16:05 ´Ù¾çÇÑ À§¾Ï ¼ö¼ú ÈÄ »îÀÇ ÁúÀ» Æò°¡ÇÏ´Â ´Ù±â°ü ÀüÇâÀû °üÂû ¿¬±¸ ÀÌÇõÁØ(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 04¿ù 20ÀÏ ±èºÎ¼·È¦ 16:05~16:20 À§¾Ï»ýÁ¸ÀÚÀÇ ¹ÌÃæÁ· ÇコÄÉ¾î ´ÏÁî ¹ß±¼À» À§ÇÑ ÀÓ»ó½ÃÇè-Áغñ- ÄÚȣƮ ¿¬±¸ ¾ö¹æ¿ï(±¹¸³¾Ï¼¾ÅÍ)

±³À°½Ã°£ 04¿ù 20ÀÏ ±èºÎ¼·È¦ 16:20~16:35 À§¾Ï »ýÁ¸ÀÚÀÇ ¼ö¼ú ÈÄ ¸¸¼º ºÎÀÛ¿ë ±Øº¹À» À§ÇÑ ÀÚ±â°Ç°­°ü¸® ÇコÄÉ¾î ½Ã½ºÅÛ °³¹ß°ú ÀÓ»óÀû È°¿ë °¡´É¼º °ËÁõ Á¤»óÈ£(°æ»óÀÇ´ë)

Åä·Ð 04¿ù 20ÀÏ ±èºÎ¼·È¦ 16:35~16:45 [Åä·ÐÀÚ] Discussion ¹Ú±â¹ü(°æºÏÀÇ´ë)

Åä·Ð 04¿ù 20ÀÏ ±èºÎ¼·È¦ 16:35~16:45 [Åä·ÐÀÚ] Discussion ÀÌÇÏ¿¹¹Î(°¡Å縯ÀÇ´ë)

±âŸ 04¿ù 20ÀÏ ±èºÎ¼·È¦ 16:45~17:50 [ÁÂÀå] Expansion of KOQUSS Research ÇãÈÆ(¾ÆÁÖÀÇ´ë)

±âŸ 04¿ù 20ÀÏ ±èºÎ¼·È¦ 16:45~17:50 [ÁÂÀå] Expansion of KOQUSS Research ¾ÈÁö¿µ(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 04¿ù 20ÀÏ ±èºÎ¼·È¦ 16:45~17:00 Scoring System of KOQUSS-40 ÀÌÁß¿±(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 04¿ù 20ÀÏ ±èºÎ¼·È¦ 17:00~17:20 Multi-center Italian Validation of the KOQUSS Questionnaire (Zoom) Maria Bencivenga(Azienda Ospedaliera Universitaria Verona (Italy))

±³À°½Ã°£ 04¿ù 20ÀÏ ±èºÎ¼·È¦ 17:20~17:40 Expansion of QOL Research in Gastric Cancer Patients (Zoom) Ziyu Li(Peking University (China))

Åä·Ð 04¿ù 20ÀÏ ±èºÎ¼·È¦ 17:40~17:50 [Åä·ÐÀÚ] Discussion ±è¼ö¹Ì(Â÷ÀÇ°ú´ë)

Åä·Ð 04¿ù 20ÀÏ ±èºÎ¼·È¦ 17:40~17:50 [Åä·ÐÀÚ] Discussion À±Á¾Çõ(¼øõÇâÀÇ´ë)

±âŸ 04¿ù 20ÀÏ ±èºÎ¼·È¦ 17:50~18:00 ¸ÎÀ½¸» Á¤»óÈ£(KOQUSS ȸÀå)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" À§¾Ï ȯÀÚ »îÀÇ Áú ¿¬±¸È¸ 2024 Ãá°è Çмú´ëȸ : 2024-04-20""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2024³â ´ëÇѳúÁ¹ÁßÇÐȸ Ãá°èÇмú´ëȸ : 2024-04-20
´ÙÀ½±Û ´ëÇÑÇ÷°ü¿Ü°úÇÐȸ16th Vascular Ultrasound Seoul Update 2023 Symposium (1ÀÏÂ÷) : 2024-04-20
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20590 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø (¿Â¶óÀÎ) 6¿ù 14ÀÏ ±Ý¿äÁý´ãȸ(¸¸¼º ºÎºñµ¿¿°ÀÇ Ä¡·á) : 2024-06-14 0 52 2024-04-29
20589 ¼­¿ï ´ëÇÑÁ¾¾ç³»°úÇÐȸ Recent updates in GI Cancer 2024 : 2024-06-14 0 23 2024-04-29
20588 ¼­¿ï ´ëÇÑ°ñ´ë»çÇÐȸ SSBH 2024 (The 12th Seoul Symposium on Bone Health)&Á¦36Â÷ Ãá°èÇмú´ëȸ 2ÀÏÂ÷ : 2024-06-14 0 33 2024-04-29
20587 ¼­¿ï ´ëÇѽÅÀåÇÐȸ APCN & KSN 2024 2ÀÏÂ÷ : 2024-06-14 0 23 2024-04-29
20586 °æºÏ 2024 ´ëÇÑÆó¾ÏÇÐȸ Ãá°èÇмú´ëȸ : 2024-06-14 0 35 2024-04-29
20585 ¼­¿ï ´ëÇѽÅÀåÇÐȸ APCN & KSN 2024 1ÀÏÂ÷ : 2024-06-13 0 22 2024-04-29
20584 ¼­¿ï ´ëÇÑ°ñ´ë»çÇÐȸ SSBH 2024 (The 12th Seoul Symposium on Bone Health)&Á¦36Â÷ Ãá°èÇмú´ëȸ 1ÀÏÂ÷ : 2024-06-13 0 36 2024-04-29
20583 ¼­¿ï (¿Â¶óÀÎ)À̺ñÀÎÈÄ°ú Áö¿ªÀÇ»çÁý´ãȸ-ÃÖ½ÅÇü º¸Ã»±â¿Í ¸ÂÃãÇü º¸Ã»±â ó¹æ¿ä·É : 2024-06-13 0 13 2024-04-29
20582 ¼­¿ï °­³²¼¼ºê¶õ½º ¾È°ú Áö¿ªÀÇ»çÁý´ãȸ(³­Ä¡¼º °¢¸· Áúȯ) : 2024-06-11 0 32 2024-04-29
20581 ¼­¿ï [¿Â¶óÀÎ] Á¦274ȸ ´ëÇÑ ¼Ò¾Æ¾Ë·¹¸£±â È£Èí±âÇÐȸ ¿ù·Ê ÇмúÁý´ãȸ(Æó±â´É°ú ±â°üÁö°ú¹Î¼º) : 2024-06-11 0 15 2024-04-29
20580 ¼­¿ï °¡Å縯´ëÇб³¼­¿ï¼º¸ðº´¿ø [¿Â¶óÀÎ] Á¦ 26 ȸ ¿Ü·¡Â÷¿øÀÇ ¼Ò¾Æû¼Ò³â°ú ÀÓ»ó : 2024-06-09 0 12 2024-04-29
20579 ¼­¿ï °í·Á´ëÇб³±¸·Îº´¿ø ¼øȯ±â³»°ú 16ȸ KOALA Symposium 2024 : 2024-06-09 0 18 2024-04-29
20578 ¼­¿ï ´ëÇÑÀ̺ñÀÎÈÄ°úÀÇ»çȸ (¿Â¶óÀÎ) Á¦3ȸ ¼ö¸é°øµ¿½ÉÆ÷Áö¾ö : 2024-06-09 0 28 2024-04-29
20577 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ 2024 ´ç´¢º´ °³¿øÀÇ ¿¬¼ö°­Á : 2024-06-09 0 35 2024-04-29
20576 ¼­¿ï 2024 ´ëÇѽŰæÁýÁßÄ¡·áÇÐȸ Ãá°èÇмú´ëȸ : 2024-06-08 0 35 2024-04-29
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷